Related Experiment Video
Updated: Jan 24, 2026
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
Published on: April 25, 2025
Nanomaterial-Based Modulation of Tumor Microenvironments for Enhancing Chemo/Immunotherapy
Quoc-Viet Le1, Juhan Suh1, Yu-Kyoung Oh2
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak gu, Seoul, 08826, Republic of Korea.
Nanomedicine utilizes nanomaterials to modify the tumor microenvironment (TME), enhancing chemotherapy and immunotherapy efficacy. Challenges like tumor penetration and heterogeneity remain key research areas for clinical translation.
Area of Science:
- Oncology
- Nanomedicine
- Biotechnology
Background:
- The tumor microenvironment (TME) is a critical target for novel cancer therapies.
- Nanomedicine offers strategies to reprogram the TME for improved treatment outcomes.
- Current approaches aim to enhance drug delivery and therapeutic efficacy by targeting TME components.
Purpose of the Study:
- To review recent advancements in using nanomaterials to modulate the TME.
- To highlight how TME modulation can improve chemotherapy and immunotherapy.
- To discuss the challenges and future directions for nanomaterial-based TME therapies.
Main Methods:
- Review of current literature on nanomaterials targeting the TME.
- Analysis of strategies for altering TME features like extracellular matrix and vasculature.
- Examination of nanomaterial applications in modulating tumor immunology.
Main Results:
- Nanomaterials can disrupt the extracellular matrix and tumor vasculature to improve drug perfusion.
- Nanoparticles can modulate immune cell populations within the TME, including fibroblasts and macrophages.
- Successful TME modulation enhances the delivery and effectiveness of anticancer agents.
Conclusions:
- Nanomaterial-based TME modulation shows significant promise for improving cancer treatment.
- Overcoming limitations such as tumor penetration, heterogeneity, and immune toxicity is crucial for clinical success.
- Further research is needed to translate these findings into effective clinical therapies.
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Self-Evaluation: Self-Enhancement and Self-Verification
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

